Sanjiang Brown Mushroom (Pholiota adiposa)

Pholiota adiposa, commonly called Sanjiang Brown Mushroom, contains bioactive polysaccharides and compounds that trigger apoptosis in cancer cells while modulating cytokine production. Its primary mechanisms involve activating immune effector pathways and reshaping gut microbiota composition in preclinical models.

Origin & History

Pholiota adiposa, known as Sanjiang Brown Mushroom, is an edible and medicinal fungus native to Northeast Asia, particularly regions like Heilongjiang Province in China. It is cultivated worldwide from domesticated variants of the wild mushroom, with polysaccharides typically extracted from the fruiting body using hot water extraction methods.

Historical & Cultural Context

Pholiota adiposa is a famous edible mushroom in Northeast Asia with a history of use for its medicinal fruiting body. Cultivation for nutritional and medicinal properties is now prevalent worldwide, driven by reported antitumor, antimicrobial, anti-HIV-1, and antioxidative activities.

Health Benefits

• May inhibit tumor growth through apoptosis induction and angiogenesis suppression (preliminary animal evidence)
• Supports immune function by elevating IL-2, IL-6, and IFN-γ levels (shown in mouse models)
• Modulates gut microbiota by increasing beneficial bacteria like Alloprevotella (preclinical data)
• Protects organ function including spleen, thymus, liver, and kidney (demonstrated in mice vs. chemotherapy-induced damage)
• Contains essential nutrients including proteins (20-25% dry weight), B vitamins, minerals, and beta-glucans (compositional analysis)

How It Works

Pholiota adiposa polysaccharides promote tumor cell death by inducing intrinsic apoptosis pathways and suppressing angiogenesis, likely by downregulating VEGF signaling critical for new blood vessel formation in tumors. On the immune side, these polysaccharides stimulate macrophage and T-cell activity, elevating pro-inflammatory and immunomodulatory cytokines including IL-2, IL-6, and IFN-γ, which coordinate adaptive immune responses. Additionally, fermentable polysaccharides act as prebiotics in the colon, selectively enriching short-chain fatty acid-producing genera such as Alloprevotella, which in turn influence intestinal barrier integrity and systemic inflammation via butyrate signaling.

Scientific Research

Research on Pholiota adiposa is limited to preclinical studies, with no human clinical trials, RCTs, or meta-analyses identified. The primary study (PMID: 35533264) used H22 hepatoma tumor-bearing mouse models, demonstrating antitumor effects comparable to cyclophosphamide through mechanisms including apoptosis induction and VEGF reduction.

Clinical Summary

Current evidence for Pholiota adiposa is limited exclusively to in vitro cell studies and rodent models, with no published human clinical trials as of 2024. Mouse model studies have demonstrated measurable increases in IL-2, IL-6, and IFN-γ serum levels following oral polysaccharide administration, suggesting immunostimulatory activity. Preclinical tumor models showed inhibited tumor growth associated with apoptosis induction and reduced angiogenic marker expression, though effect sizes and dosing protocols vary across studies. Gut microbiota research in rodents identified significant enrichment of Alloprevotella after supplementation, but translation to human microbiome outcomes remains unestablished.

Nutritional Profile

Sanjiang Brown Mushroom (Pholiota adiposa) is a high-protein, low-fat edible fungus with notable bioactive compound diversity. **Macronutrients (per 100 g dry weight, approximate):** Protein: 18–25 g (rich in essential amino acids including leucine, lysine, and valine); Total fat: 1.5–3.5 g; Total carbohydrates: 50–60 g (including significant dietary fiber); Crude fiber/dietary fiber: 6–10 g (comprising both β-glucans and chitin); Ash: 5–8 g. **Caloric value:** ~280–320 kcal per 100 g dry weight. Fresh fruiting bodies are approximately 85–92% moisture, yielding roughly 25–40 kcal per 100 g fresh weight. **Key Bioactive Compounds:** • Polysaccharides (primarily β-glucans, particularly β-1,3/1,6-D-glucans): ~3–8% of dry weight; these are the principal immunomodulatory and antitumor-active fractions. Bioavailability is moderate orally; gut microbiota fermentation enhances activity. • Phenolic compounds: total phenolics approximately 5–15 mg GAE/g dry weight, including gallic acid, protocatechuic acid, and flavonoids, contributing to antioxidant capacity (DPPH/ABTS radical scavenging). • Adipose-specific sesquiterpenes and diterpenoids: trace to low concentrations, some with cytotoxic activity (exact quantities vary by strain and substrate). • Ergosterol (provitamin D₂): ~50–100 mg/100 g dry weight; convertible to vitamin D₂ upon UV-B exposure. **Minerals (per 100 g dry weight, approximate):** Potassium: 2,000–3,500 mg; Phosphorus: 600–1,000 mg; Magnesium: 100–200 mg; Calcium: 20–60 mg; Iron: 10–30 mg; Zinc: 5–12 mg; Selenium: 2–15 µg (substrate-dependent; bioavailability is moderate as organoselenium forms). Copper: 1–5 mg; Manganese: 1–3 mg. **Vitamins:** Niacin (B₃): 30–60 mg/100 g dry weight; Riboflavin (B₂): 1–4 mg; Thiamine (B₁): 0.1–0.5 mg; Folate (B₉): 30–60 µg; Vitamin D₂: variable, 0–1,200 IU depending on UV exposure. **Other notable compounds:** • Lectins: present in trace amounts; may contribute to immunomodulatory effects. • Trehalose: 1–3% dry weight (a natural disaccharide with potential cytoprotective properties). • Chitin and chitosan derivatives in cell walls: partially contribute to dietary fiber but have low digestibility/bioavailability. • Fatty acid profile (of the lipid fraction): predominantly linoleic acid (C18:2, ~55–70% of total fatty acids), oleic acid (C18:1, ~15–25%), and palmitic acid (C16:0, ~10–15%). **Bioavailability notes:** β-glucan polysaccharides are not directly absorbed intact but exert immunomodulatory effects via gut-associated lymphoid tissue (GALT) and Peyer's patches; hot-water extraction significantly increases their bioaccessibility. Phenolic antioxidants show moderate oral bioavailability. Mineral bioavailability may be slightly reduced by phytate-like compounds and oxalates naturally present. Protein digestibility is generally good (~70–80% PDCAAS estimated) once cell walls are disrupted by cooking.

Preparation & Dosage

No clinically studied dosages in humans are available. Preclinical mouse studies used unspecified low, medium, and high doses of hot water extract (EPA), with the high dose showing strongest tumor inhibition. Human dosing has not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Reishi mushroom, Turkey tail, Shiitake, Vitamin D, Probiotics

Safety & Interactions

No formal human safety trials have been conducted for Pholiota adiposa extracts or supplements, making comprehensive risk profiling impossible at this time. Given its immunostimulatory cytokine-elevating properties—specifically IL-2, IL-6, and IFN-γ—individuals taking immunosuppressant drugs such as cyclosporine or corticosteroids should exercise caution due to potential antagonistic interactions. Pregnant and breastfeeding individuals should avoid supplementation in the absence of safety data. Individuals with autoimmune conditions such as lupus, rheumatoid arthritis, or multiple sclerosis should consult a physician before use, as immune upregulation could theoretically exacerbate disease activity.